Airflow limitation more than doubles the risk for hospitalization/mortality in patients with heart failure

被引:3
作者
Bugajski, Andrew [1 ]
Frazier, Susan K. [2 ]
Moser, Debra K. [2 ]
Chung, Misook [2 ]
Lennie, Terry A. [2 ]
机构
[1] Univ S Florida, Coll Nursing, 12901 Bruce B Downs Blvd, Tampa, FL 33612 USA
[2] Univ Kentucky, Coll Nursing, Lexington, KY 40506 USA
关键词
Chronic obstructive pulmonary disease; heart failure; airflow limitation; survival; OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; LUNG-FUNCTION; PATHOPHYSIOLOGY; PREVALENCE; MORTALITY; DYSPNEA; ANXIETY; IMPACT;
D O I
10.1177/1474515118822373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Comorbid chronic obstructive pulmonary disease is found in approximately one-third of patients with heart failure. Survival in patients with chronic obstructive pulmonary disease generally decreases as lung function declines. However, the association between lung function, hospitalization and survival is less clear for patients with heart failure. Aim: The purpose of this study was to determine the predictive power of spirometry measures for event-free survival (combined all-cause hospitalization and/or mortality) in patients with heart failure. Methods: In this secondary analysis of data from three prospective, longitudinal studies, we selected patients with a confirmed diagnosis of heart failure who completed airflow limitation assessment using spirometry measures (n=137): forced vital capacity, forced expiratory volume/second, and forced expiratory volume/second/forced vital capacity. Cox proportional hazards modeling was used to determine the relationship between spirometry and all-cause hospitalization/mortality with and without adjusting for demographic and clinical covariates over a four-year follow-up period. Results: A majority (74%) exhibited some degree of airflow limitation (forced expiratory volume/second<80% predicted value) and 26 (19%) met the spirometric criterion for chronic obstructive pulmonary disease (forced expiratory volume/second/forced vital capacity <= 0.70). Cox proportional hazards regression models compared all-cause hospitalization/mortality between those with and without airflow limitation. Patients with airflow limitation were 2.2 times more likely to be hospitalized or die compared to those without airflow limitations (hazard ratio: 2.20, 95% confidence interval 1.06-4.53, p=0.03). Conclusion: Patients with comorbid heart failure and airflow limitation were at more than double the risk for an event. Spirometric measures may be useful to patients with heart failure, as tailored management of airflow limitation may impact event-free survival.
引用
收藏
页码:245 / 252
页数:8
相关论文
共 38 条
  • [1] [Anonymous], BURD COPD
  • [2] Pathophysiology of dyspnea in COPD
    Anzueto, Antonio
    Miravitlles, Marc
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (03) : 366 - 374
  • [3] Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure
    Arnaudis, Brice
    Lairez, Olivier
    Escamilla, Roger
    Fouilloux, Audrey
    Fournier, Pauline
    Monteil, Benoit
    Bouisset, Frederic
    Arnal, Jean-Francois
    Elbaz, Meyer
    Carrie, Didier
    Roncalli, Jerome
    Pathak, Atul
    Galinier, Michel
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2012, 101 (09) : 717 - 726
  • [4] β-Blockers, heart disease and COPD: current controversies and uncertainties
    Baker, Jillian G.
    Wilcox, Robert G.
    [J]. THORAX, 2017, 72 (03) : 271 - 276
  • [5] Impact of airflow limitation in chronic heart failure
    Bektas, S.
    Franssen, F. M. E.
    van Empel, V.
    Uszko-Lencer, N.
    Boyne, J.
    Knackstedt, C.
    Brunner-La Rocca, H. P.
    [J]. NETHERLANDS HEART JOURNAL, 2017, 25 (05) : 335 - 342
  • [6] The Impact of Repeat Hospitalizations on Hospitalization Rates for Selected Conditions Among Adults With and Without Diabetes, 12 US States, 2011
    Benjamin, Stephanie M.
    Wang, Jing
    Geiss, Linda S.
    Thompson, Theodore J.
    Gregg, Edward W.
    [J]. PREVENTING CHRONIC DISEASE, 2015, 12
  • [7] Heart Failure-Associated Hospitalizations in the United States
    Blecker, Saul
    Paul, Margaret
    Taksler, Glen
    Ogedegbe, Gbenga
    Katz, Stuart
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (12) : 1259 - 1267
  • [8] Lung function indices for predicting mortality in COPD
    Boutou, Afroditi K.
    Shrikrishna, Dinesh
    Tanner, Rebecca J.
    Smith, Cayley
    Kelly, Julia L.
    Ward, Simon P.
    Polkey, Michael I.
    Hopkinson, Nicholas S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (03) : 616 - 625
  • [9] The pathophysiology of pulmonary hypertension in left heart disease
    Breitling, Siegfried
    Ravindran, Krishnan
    Goldenberg, Neil M.
    Kuebler, Wolfgang M.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2015, 309 (09) : L924 - L941
  • [10] Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals
    Conrad, Nathalie
    Judge, Andrew
    Tran, Jenny
    Mohseni, Hamid
    Hedgecott, Deborah
    Crespillo, Abel Perez
    Allison, Moira
    Hemingway, Harry
    Cleland, John G.
    McMurray, John J. V.
    Rahimi, Kazem
    [J]. LANCET, 2018, 391 (10120) : 572 - 580